STARLIMS, a global leader in Laboratory Information Management Systems (LIMS) and informatics solutions, today announced ...
Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to License Global Rights to an Early-Stage ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free ...
Chemify raises > US $50 million in Series B funding to globalise its AI-driven digital chemistry and molecule-manufacturing ...
This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and ...
Named after Dr. James Robert Cade, the lead inventor of Gatorade, the Cade Prize for Inventivity celebrates early-stage ...
New tool helps sponsors measure, manage and minimize the environmental impact of researchWILMINGTON, N.C.--(BUSINESS ...
Black Book survey reveals just 1 in 4 hospitals can fully exchange patient data across national boundaries in Q4 2025 VIENNA, ...
IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation
IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic ...
Challenges and New Momentumchina’s pharmaceutical innovation goes global challenges and new momentumIn the first five months ...
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
ROCKVILLE, MD / ACCESS Newswire / October 21, 2025 / Radiation therapy has always been the heavyweight of cancer treatment. It works, but it's a brute. It blasts cancer cells, hoping the good ones can ...
Co-led by Wing Venture Capital and Insight Partners, the financing will scale Chemify’s Chemputation platform and Chemifarm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback